Search research articles
Contact Us
Filters
Showing results (211-220 of 284) with videos related to
Page
of 29
Sort By:
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Clinical Colorectal Cancer
|
June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
Filippo Pietrantonio, Federica Morano, Monica Niger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
Federica Morano, Salvatore Corallo, Sara Lonardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials
Roberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer
Jim P Abraham, Daniel Magee, Chiara Cremolini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
Guillem Argilés, Nuria Mulet, Manuel Valladares-Ayerbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K Morris, Erin B Kennedy, Nancy N Baxter, et al.
British Journal of Cancer
|
May 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
JAMA Oncology
|
February 17, 2018
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial
Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 284) with videos related to
Sort By:
Page
of 29
The New England Journal of Medicine
|
June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Eileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Clinical Colorectal Cancer
|
June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
Filippo Pietrantonio, Federica Morano, Monica Niger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
Federica Morano, Salvatore Corallo, Sara Lonardi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials
Roberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer
Jim P Abraham, Daniel Magee, Chiara Cremolini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
Guillem Argilés, Nuria Mulet, Manuel Valladares-Ayerbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K Morris, Erin B Kennedy, Nancy N Baxter, et al.
British Journal of Cancer
|
May 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Umberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.
JAMA Oncology
|
February 17, 2018
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial
Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, et al.
Page
of 29